3-hydroxybutyrate

BIOLOGICAL2 trials

Sponsors

University of Aarhus

Conditions

Diabetic KetoacidosisKetoses, MetabolicType 1 Diabetes MellitusType 2 Diabetes

Unknown Phase

Metabolic Effects of Exogenous 3-hydroxybutyrate in Patients With Type 1 Diabetes and Healthy Controls

CompletedNCT04656236

University of AarhusDiabetic Ketoacidosis, Type 1 Diabetes Mellitus

Start: 2021-01-01End: 2022-03-01Updated: 2022-03-08

Keto Drinks as a Meal Primer in Patients With Type 2 Diabetes

CompletedNCT05263401

University of AarhusKetoses, Metabolic, Type 2 Diabetes

Start: 2022-01-01End: 2022-09-30Updated: 2023-04-04

Related Papers

Ketosis elevates plasma concentrations of D-β-hydroxybutyryl-phenylalanine (BHB-Phe) in humans

Nutrition & Metabolism2026-07-15

Ketone supplementation dose-dependently lowers postprandial blood glucose, lipid and ghrelin levels in individuals with type 2 diabetes: a randomised crossover study.

2025-11-28

Metabolic effects of 3-hydroxybutyrate infusion in individuals with type 1 diabetes compared with healthy control participants: a randomised crossover trial showing intact feedback suppression of lipolysis

Diabetologia2025-04-102 citations